The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease
Abstract
Prior to any evaluation of morphologic brain changes, a decision must be made whether a given alteration is associated with aging or with disease. Patients with disease-related lesions may be in a clinically silent phase of a disease or show overt symptoms. Neurofibrillary tangles and neuropil threads are the hallmarks of Alzheimer's disease. They should not be considered to be age-related changes, even when they are present only in small numbers. In general, the initial changes consist of neurofibrillary tangles and neuropil threads. Plaques (amyloid deposits and/or neuritic plaques) are consistently present in the end stage of the disease. Initial neurofibrillary tangles and neuropil threads develop at specific cortical predilection sites. The changes then spread in a predictable, nonrandom manner across other portions of the telencephalic cortex. The sequential changes in the distribution pattern of the lesions provide the basis for a staging procedure that takes the slow and gradual progression of the destructive process into consideration. The staging procedure provides accurate diagnoses in the initial stages and even reveals brain changes developing prior to the appearance of clinical symptoms. It is thus advantageous in characterizing nondemented controls. The staging procedure can be carried out easily and does not require knowledge of clinical data, quantitative assessments, or adjustments for the age of the patients. Application of advanced silver techniques (Gallyas, Campbell-Switzer) to demonstrate Alzheimer's disease-related lesions also allows recognition of the hallmarks of other disorders, such as Lewy body disease (Parkinson's disease) and dementia with argyrophilic grains, which frequently co-occur with Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Initial neurofibrillary tangles and neuropil threads develop in the entorhinal cortex, then the hippocampus, and gradually affect additional brain regions as the disease progress, eventually affecting the neocortex [57].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [57]
In the citing paper
“Postmortem studies have shown that the spread of tau pathology in AD follows a predictable pattern, allowing neuropathological diagnosis of different AD stages defined by Braak staging (I–VI).”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [57]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citationMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769
Self-citationAlzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 752
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 721
The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings
Albert Hofman, D., Rocca, W. A., Brayne, C., Breteler, M. M. B., Clarke, M., Cooper, B. K., Copeland, J. R. M., Dartigues, J. F., Droux, A. D. S., Hagnell, O., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.3.736 · Cited by 667
Research works printed but not linked: 1
- Duyckaerts, 1994, Diagnosis and staging of Alzheimer’s disease in a prospective study involving aged individuals, Neurobiol. Aging, 15, 140
Cited by
Sorted by citations
Items 101–200 of 409
Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration
Steinbrink, F., Evers, S., Buerke, B., Young, P., Arendt, G., Koutsilieri, E., Reichelt, D., Lohmann, H., Husstedt, I. W., & the German Competence Network HIV/AIDS (2012) · European Journal of Neurology · doi:10.1111/ene.12006 · Cited by 88
Kuo, S., Tang, G., Louis, E. D., Ma, K., Babji, R., Balatbat, M., Cortes, E. P., Vonsattel, J., Yamamoto, A., Sulzer, D. L., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1108-7 · Cited by 83
Differential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease
Kulstad, J. J., Green, P. S., Cook, D. G., Watson, G. S., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Rhoads, K., Mehta, P. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000216274.58185.09 · Cited by 84
Increased number of Purkinje cell dendritic swellings in essential tremor
Yu, M., Ma, K., Faust, P. L., Honig, L. S., Cortés, E., Vonsattel, J., & Louis, E. D. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03598.x · Cited by 82
Singulani, M. P., Pereira, C. P. M., Ferreira, A. F. F., Garcia, P. C., Ferrari, G. D., Alberici, L. C., & Britto, L. R. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110882 · Cited by 81
Evaluation of 18F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain
Kuwabara, H., Comley, R., Borroni, E., Honer, M., Kitmiller, K., Roberts, J., Gapasin, L., Mathur, A., Klein, G., & Wong, D. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.214437 · Cited by 72
Louis, E. D., Babij, R., Lee, M., Cortes, E. P., & Vonsattel, J. (2013) · Movement Disorders · doi:10.1002/mds.25629 · Cited by 78
Contextualizing the pathology in the essential tremor cerebellar cortex: a patholog-omics approach
Louis, E. D., Kerridge, C. A., Chatterjee, D., Martuscello, R. T., Diaz, D. T., Koeppen, A. H., Kuo, S., Vonsattel, J., Sims, P. A., & Faust, P. L. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02043-7 · Cited by 76
Parachikova, A. I., & Cotman, C. W. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.001 · Cited by 77
“However, plaque pathology is a poor correlate of the degree of memory impairment (Braak and Braak, 1997; Crystal et al., 1988; Polvikoski et al., 2001).”
BackgroundCalhoun-Haney, R., & Murphy, C. A. (2004) · Brain and Cognition · doi:10.1016/j.bandc.2004.10.004 · Cited by 76
“Braak and Braak (1991, 1997) describe the initial lesions from neuroWbrillary tangles occurring in the transentorhinal and entorhinal regions, areas critical for olfactory function.”
BackgroundThe EMIF-AD PreclinAD study: study design and baseline cohort overview
Konijnenberg, E., Carter, S. F., ten Kate, M., den Braber, A., Tomassen, J., Amadi, C., Wesselman, L. M. P., Nguyen, H., van de Kreeke, J. A., Yaqub, M. M., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0406-7 · Cited by 77
“Alzheimer’s disease (AD) is the most common cause of dementia and is characterized by amyloid plaques and neurofibrillary tangles with subsequently progressive neuronal loss and eventually death [1].”
BackgroundSynaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease
Torres, A. K., Jara, C., Park-Kang, H. S., Polanco, C. M., Tapia, D., Alarcón, F., de la Peña, A., Llanquinao, J., Vargas-Mardones, G., Álvarez‐Indo, J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215139 · Cited by 80
“Although there are several studies showing that A (cid:2) pathology induce hyperphosphorylated tau pathology, there are studies that discuss the fact that the first stages of tau pathology may occur before A (cid:2) depositions [26, 27].”
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
Höglund, K., Kern, S., Zettergren, A., Börjesson‐Hanson, A., Zetterberg, H., Skoog, I. G., & Blennow, K. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.252 · Cited by 74
Feature selection using factor analysis for Alzheimer's diagnosis using PET images
Salas-Gonzalez, D., Górriz, J. M., Ramı́rez, J., Illán, I. A., López, M., Segovia, F., Chaves, R., Padilla, P., Puntonet, C. G., & Initiative, T. A. D. N. (2010) · Medical Physics · doi:10.1118/1.3488894 · Cited by 74
Gulyás, B. Z., Makkai, B., Kása, P., Gulya, K., Bakota, L., Várszegi, S., Beliczai, Z., Andersson, J. D., Csiba, L., Thiele, A., et al. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.001 · Cited by 74
Molecular Genetics of Neurodegenerative DementiasPreprint
Hinz, F. I., & Geschwind, D. H. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023705 · Cited by 76
“The presence of NFTs is strongly correlated with neuronal dysfunction and disease progression (for reviews of AD pathology, see Braak and Braak 1997, 1998; Serrano-Pozo et al. 2011).”
BackgroundMarkus, R. P., Silva, C. L. M., Franco, D. G., Barbosa, E. M., & Ferreira, Z. S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.009 · Cited by 74
Older onset essential tremor: More rapid progression and more degenerative pathology
Louis, E. D., Faust, P. L., Vonsattel, J., Honig, L. S., Henchcliffe, C., Pahwa, R., Lyons, K. E., Rios, E., Erickson-Davis, C. R., Moskowitz, C. B., et al. (2009) · Movement Disorders · doi:10.1002/mds.22570 · Cited by 73
The tetrapartite synapse: a key concept in the pathophysiology of schizophrenia
Chelini, G., Pantazopoulos, H., Durning, P. T., & Berretta, S. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.02.003 · Cited by 73
“Subjects with Braak stages III or higher [157] (modified Bielschowsky stain) were not included.”
Torpedoes in the Cerebellar Vermis in Essential Tremor Cases vs. Controls
Louis, E. D., Faust, P. L., Ma, K. J., Yu, M., Cortes, E. P., & Vonsattel, J. (2011) · The Cerebellum · doi:10.1007/s12311-011-0291-0 · Cited by 72
“Each brain received a Braak and Braak Alzheimer’s disease (AD) stage for neurofibrillary tangles (NFTs) [ 23 ] and Consortium to Establish a Registry for AD (CERAD) ratings for neuritic plaques [24].”
MethodAltered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers
Borghesani, P. R., Johnson, L. C., Shelton, A. L., Peskind, E. R., Aylward, E., Schellenberg, G. D., & Cherrier, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.012 · Cited by 70
Functional Representation of Olfactory Impairment in Early Alzheimer's Disease
Förster, S., Vaitl, A., Teipel, S. J., Yakushev, I. Y., Mustafa, M., la Fougère, C. J., Rominger, A., Cumming, P. D., Bartenstein, P., Hampel, H. J., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091549 · Cited by 70
“These consistent findings of an early impairment of olfaction in AD seem consistent with the early pathological changes in brain areas that are strongly involved with processing of olfactory information, as well as memory consolidation [13].”
Altered microglia and neurovasculature in the Alzheimer's disease cerebellum
Singh‐Bains, M. K., Linke, V., Austria, M. D. R., Tan, A. Y. S., Scotter, E. L., Mehrabi, N. F., Faull, R. L. M., & Dragunow, M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104589 · Cited by 74
Computer aided diagnosis of Alzheimer’s disease using component based SVM
Illán, I. A., Górriz, J. M., López, M., Ramı́rez, J., Salas-Gonzalez, D., Segovia, F., Chaves, R., & Puntonet, C. G. (2010) · Applied Soft Computing · doi:10.1016/j.asoc.2010.08.019 · Cited by 69
“These regions are believed to be first affected by the disease, despite the difficulties of imaging these deep brain structures [4,3].”
BackgroundSilvestrelli, G., Lanari, A., Parnetti, L., Tomassoni, D., & Amenta, F. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.018 · Cited by 73
Dukart, J., Sambataro, F., Bertolino, A., & Initiative, A. D. N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150570 · Cited by 68
Clinical Validity of Aß-Protein Deposition Staging in Brain Aging and Alzheimer Disease
Gold, G., Kövari, E., Corte, G., Herrmann, F. R., Canuto, A., Bussière, T., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.10.946 · Cited by 67
The effects of acute and repeated oroxylin A treatments on Aβ25–35-induced memory impairment in mice
Kim, D., Kim, S., Jeon, S. J., Son, K. H., Lee, S., Yoon, B. H., Cheong, J. H., Ko, K. H., & Ryu, J. H. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.019 · Cited by 67
Swerdlow, N., & Wilkins, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249661 · Cited by 66
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice
Sigurdsson, E. M., Wadghiri, Y. Z., Mosconi, L., Blind, J. A., Knudsen, E., Asuni, A. A., Scholtzova, H., Tsui, W. H., Li, Y., Sadowski, M. J., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.018 · Cited by 66
The inferior olivary nucleus: A postmortem study of essential tremor cases versus controls
Louis, E. D., Babij, R., Cortes, E. P., Vonsattel, J., & Faust, P. L. (2013) · Movement Disorders · doi:10.1002/mds.25400 · Cited by 66
Synaptophysin and Synaptojanin-1 in Down Syndrome are Differentially Affected by Alzheimer's Disease
Martin, S. B., Dowling, A. L. S., Lianekhammy, J., Lott, I. T., Doran, E., Murphy, M. P., Beckett, T. L., Schmitt, F. A., & Head, E. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140795 · Cited by 64
“for a diagnosis of AD [30].”
Mäkinen, S., van Groen, T., Clarke, J., Thornell, A., Corbett, D., Hiltunen, M. O., Soininen, H. S., & Jolkkonen, J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600529 · Cited by 64
“b-Amyloid is a major component of senile plaques, one of the pathological hallmarks of Alzheimer’s disease (Braak and Braak, 1997).”
BackgroundAmyloid beta peptide directly inhibits PKC activation
Lee, W., Boo, J. H., Jung, M. W., Park, S. D., Kim, Y. H., Kim, S. U., & Mook‐Jung, I. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.10.020 · Cited by 65
Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia
Iráizoz, I., Guijarro, J. L., Gonzalo, L. M., & Lacalle, S. D. (1999) · Acta Neuropathologica · doi:10.1007/s004010051068 · Cited by 61
“Furthermore, since neurofibrillary changes of the Alzheimer type do not inevitably occur in the brain of aged individuals, NFT must be considered abnormal [ 20 ].”
BackgroundAmyloid-β: A double agent in Alzheimer's disease?
Yu, H., & Wu, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111575 · Cited by 62
Alzheimer’s Disease and Stem Cell Therapy
Choi, S. S., Lee, S., Kim, S. U., & Lee, H. J. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.1.45 · Cited by 62
Obayashi, M., Stévanin, G., Synofzik, M., Monin, M., Duyckaerts, C. J., Sato, N. J., Streichenberger, N., Vighetto, A., Desestret, V., Tesson, C., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309153 · Cited by 62
Fan, Q., He, W., Gayen, M., Benoit, M. R., Luo, X., Hu, X., & Yan, R. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.1333-19.2019 · Cited by 58
Louis, E. D., Martuscello, R. T., Gionco, J. T., Hartstone, W. G., Musacchio, J. B., Portenti, M., McCreary, M., Kuo, S., Vonsattel, J., & Faust, P. L. (2023) · Acta Neuropathologica · doi:10.1007/s00401-022-02535-z · Cited by 59
Rüb, U., Tredici, K. D., Turco, D. D., & Braak, H. (2002) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(02)00007-8 · Cited by 58
Self-citationNeuropsychological Predictors of Dementia in Late-Life Major Depressive Disorder
Potter, G. G., Wagner, H. R., Burke, J. R., Plassman, B. L., Welsh-Bohmer, K. A., & Steffens, D. C. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.009 · Cited by 56
Salas-González, D., Górriz, J., Ramírez, J., López, M. R., Illán, I. Á., Segovia, F., Chaves, R., & Puntonet, C. (2010) · Physics in Medicine and Biology · doi:10.1088/0031-9155/55/10/002 · Cited by 73
“Alzheimer’s diagnosis is usually based on the information provided by a careful clinical examination, a thorough interview of the patient and relatives and a neuropsychological assessment (Braak and Braak 1997, Cummings et al 1998, Hoffman et al 2000, Ng et al 2007).”
MethodHiltunen, M. O., van Groen, T., & Jolkkonen, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1154 · Cited by 62
“in the series of pathological changes occurring during AD, eventually characterized by the appearance of the typical neuritic plaques [1].”
Optical coherence tomography visualizes neurons in human entorhinal cortex
Magnain, C. V., Augustinack, J. C., Konukoğlu, E., Frosch, M. P., Sakadžić, S., Michaud, A., Garcia, N., Wedeen, V. J., Boas, D. A., & Fischl, B. R. (2015) · Neurophotonics · doi:10.1117/1.nph.2.1.015004 · Cited by 56
Mazère, J., Prunier, C., Barret, O., Guyot, M., Hommet, C., Guilloteau, D., Dartigues, J. F., Auriacombe, S., Fabrigoule, C., & Michèle Allard, A. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.11.028 · Cited by 55
Contribution of neural networks to Alzheimer disease's progression
Savioz, A., Leuba, G., Vallet, P. G., & Walzer, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.006 · Cited by 59
“The progressive dysconnection of temporal and then all associative areas matches temporally primary memory loss and following cognitive deficits leading to dementia [2,10–13].”
BackgroundWang, Q., Chen, B., Zhong, X., Zhou, H., Zhang, M., Mai, N., Wu, Z., Huang, X., Haehner, A., Chen, X., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201168 · Cited by 55
β‐Amyloid Induces Oxidative DNA Damage and Cell Death through Activation of c‐Jun N Terminal Kinase
Jang, J.-H., & Surh, Y. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04639.x · Cited by 54
Dhage, P. A., Sharbidre, A. A., Dakua, S. P., & Balakrishnan, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111634 · Cited by 53
Automatic Classification of SPECT Images of Alzheimer’s Disease Patients and Control Subjects
Stoeckel, J., Ayache, N., Malandain, G., Koulibaly, P. M., Ebmeier, K. P., & Darcourt, J. (2004) · Lecture notes in computer science · doi:10.1007/978-3-540-30136-3_80 · Cited by 53
Hypertension, cerebrovascular impairment, and cognitive decline in aged AβPP/PS1 mice
Wiesmann, M., Zerbi, V., Jansen, D., Lütjohann, D., Veltien, A. A., Heerschap, A., & Kiliaan, A. J. (2017) · Theranostics · doi:10.7150/thno.18509 · Cited by 54
Drosophila Glia: Models for Human Neurodevelopmental and Neurodegenerative Disorders
Kim, T., Song, B., & Lee, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144859 · Cited by 57
Yi, J. H., Park, H. J., Lee, S., Jung, J. W., Kim, B. C., Lee, Y. C., Ryu, J. H., & Kim, D. H. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.007 · Cited by 52
Agadjanyan, M. G., Zagorski, K., Petrushina, I., Davtyan, H., Kazarian, K., Antonenko, M., Davis, J. L., Bon, C., Blurton-Jones, M. M., Cribbs, D. H., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0172-1 · Cited by 56
Cao, K., Dong, Y., Xiang, J., Xu, Y., Hong, W., Song, H., & Guan, Z.-Z. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205320 · Cited by 53
Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease
Nagarsheth, M. H., Viehman, A., Lippa, S. M., & Lippa, C. F. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.01.007 · Cited by 52
“Although we described Notch-1 immunoreactivity in this case, we left this case out of the statistical analysis since he did not fully meet diagnostic clinical or pathological criteria for AD [9,6,7].”
BackgroundGámez‐Valero, A., & Beyer, K. (2018) · Genes · doi:10.3390/genes9020063 · Cited by 51
Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies
d’Abramo, C., Acker, C. M., Jimenez, H. T., & Davies, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135774 · Cited by 49
Dowling, N. M., Farias, S. T., Reed, B., Sonnen, J. A., Strauss, M. E., Schneider, J. A., Bennett, D. A., & Mungas, D. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710001426 · Cited by 47
Imaging Alzheimer's genetic risk using diffusion MRI: A systematic review
Harrison, J. R., Bhatia, S., Tan, Z. X., Mirza-Davies, A., Benkert, H., Tax, C. M. W., & Jones, D. K. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102359 · Cited by 50
“According to this hypothesis, patterns of white matter alterations should correspond to grey matter pathology, occurring first in the hippocampal and entorhinal areas, before extending to wider temporal and parietal regions (Braak & Braak, 1997).”
Plassman, B. L., Khachaturian, A. S., Townsend, J. J., Ball, M. J., Steffens, D. C., Leslie, C., Tschanz, J. T., Norton, M. C., Burke, J. R., Welsh-Bohmer, K. A., et al. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.11.001 · Cited by 46
Förster, S., Yousefi, B. H., Wester, H.-J., Klupp, E., Rominger, A., Förstl, H., Kurz, A., Grimmer, T., & Drzezga, A. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2230-9 · Cited by 45
Torpedo Formation and Purkinje Cell Loss: Modeling their Relationship in Cerebellar Disease
Louis, E. D., Kuo, S., Vonsattel, J., & Faust, P. L. (2014) · The Cerebellum · doi:10.1007/s12311-014-0556-5 · Cited by 46
Illán, I. A., Górriz, J. M., Ramı́rez, J., Salas-Gonzalez, D., López, M., Segovia, F., Padilla, P., & Puntonet, C. G. (2010) · Pattern Recognition Letters · doi:10.1016/j.patrec.2010.03.004 · Cited by 46
Cerebellar Pathology in Early Onset and Late Onset Essential Tremor
Kuo, S., Wang, J., Tate, W. J., Pan, M., Kelly, G. C., Gutierrez, J., Cortes, E. P., Vonsattel, J., Louis, E. D., & Faust, P. L. (2016) · The Cerebellum · doi:10.1007/s12311-016-0826-5 · Cited by 45
“brain in a cold room or upon ice), Braak and Braak AD staging for neurofibrillary tangles [23, 24], and Consortium to Establish a Registry for AD (CERAD) ratings for neuritic plaques [25].”
BackgroundSchubert, C. R., Cruickshanks, K. J., Fischer, M., Pinto, A. A., Chen, Y., Huang, G.-H., Klein, R., Klein, R., Pankow, J. S., Paulsen, A. J., et al. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz011 · Cited by 42
“Aging and disease-related pathology have been shown to begin early in areas of the brain associated with olfactory processing, and the amount and type of pathology in these areas has been correlated with performance on odor identification tests proximal to death (32,33).”
BackgroundNeurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases
Otto, M., Lewczuk, P., & Wiltfang, J. (2008) · Methods · doi:10.1016/j.ymeth.2007.06.012 · Cited by 44
Rüb, U., Tredici, K. D., Schultz, C., Büttner-Ennever, J. A., & Braak, H. (2001) · Vision Research · doi:10.1016/s0042-6989(01)00090-6 · Cited by 44
Self-citationElevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls
Louis, E. D., Factor-Litvak, P. R., Liu, X., Vonsattel, J., Galecki, M., Jiang, W., & Zheng, W. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.07.002 · Cited by 43
Multimodal Voxel-Based Meta-Analysis of White Matter Abnormalities in Alzheimer’s Disease
Yin, R.-H., Tan, L., Liu, Y., Wang, W.-Y., Wang, H.-F., Jiang, T., Raduà, J., Zhang, Y., Gao, J., Canu, E., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150139 · Cited by 42
Moreno‐González, I., Baglietto‐Vargas, D., Sanchez-Varo, R. M., Jiménez, S., Trujillo‐Estrada, L., Sánchez‐Mejías, E., del Río, J. C., Torres, M., Romero‐Acebal, M., Ruano, D., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1192 · Cited by 42
Cuadrado‐Tejedor, M., Ricobaraza, A., Río, J. D., Frechilla, D., Franco, R., Pérez‐Mediavilla, A., & García‐Osta, A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.005 · Cited by 42
Hin, N., Newman, M., Kaslin, J., Douek, A. M., Lumsden, A. L., Nik, S. H. M., Dong, Y., Zhou, X., Manucat-Tan, N. B., Ludington, A. J., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227258 · Cited by 40
“Many people also have brains containing high levels of Aβ [83] or Braak stage III to VI neurodegeneration [79] without obvious dementia.”
BackgroundInfluentialPeisah, C., Snowdon, J., Gorrie, C., Kril, J., & Rodriguez, M. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.030 · Cited by 37
Beyer, K., Domingo-Sàbat, M., dos Santos, C. M. P., TOLOSA, E. S., Ferrer, I., & Ariza, A. (2010) · Brain · doi:10.1093/brain/awq275 · Cited by 41
Sharma, H., & Chandra, P. (2023) · International Journal of Pharmaceutical Investigation · doi:10.5530/ijpi.14.1.15 · Cited by 47
Kukolja, J., Thiel, C. M., Eggermann, T., Zerres, K., & Fink, G. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.044 · Cited by 40
“We primarily focused our nalysis on the medial temporal lobe since its structures re among the earliest to show AD-related pathology Braak and Braak, 1997).”
BackgroundŞİRİN, F. B., Doğuç, D. K., Vural, H., Eren, İ., İnanlı, İ., Sütçü, R., & Delibaş, N. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1406-134 · Cited by 39
Russo, C., Dolcini, V., Salis, S., Venezia, V., Violani, E., Carlo, P., Zambrano, N., Russo, T., & Schettini, G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04660.x · Cited by 39
Interactions between amyloid, amyloid precursor protein, and mitochondria
Wilkins, H. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220518 · Cited by 37
Medullary autonomic pathology in carotid sinus hypersensitivity
Miller, V. M., Kenny, R. A., Slade, J. Y., Oakley, A. E., & Kalaria, R. N. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00903.x · Cited by 43
Chu, W. T., Wang, W., Záborszky, L., Golde, T. E., DeKosky, S. T., Duara, R., Loewenstein, D., Adjouadi, M., Coombes, S. A., & Vaillancourt, D. E. (2021) · Neurology · doi:10.1212/wnl.0000000000013206 · Cited by 36
Diffusion tensor imaging of the hippocampus predicts the risk of dementia; the RUN DMC study
van Uden, I. W. M., Tuladhar, A. M., van der Holst, H. M., van Leijsen, E. M. C., van Norden, A. G. W., de Laat, K. F., Rutten‐Jacobs, L. C. A., Norris, D. G., Claassen, J. A. H. R., van Dijk, E. J., et al. (2015) · Human Brain Mapping · doi:10.1002/hbm.23029 · Cited by 36
Ren, Z., Yang, M., Guan, Z.-Z., & Yu, W. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666181022093359 · Cited by 36
Šišková, Z., Reynolds, R. A., O'Connor, V. M., & Perry, V. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055004 · Cited by 35
Nucleotide excision repair in chronic neurodegenerative diseases
Sepe, S., Payán‐Gómez, C., Milanese, C., Hoeijmakers, J. H. J., & Mastroberardino, P. G. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.009 · Cited by 35
Xu, L., Ren, Z., Chow, F. E., Tsai, R., Liu, T., Rizzolio, F., Boffo, S., Xu, Y., Huang, S., Lippa, C. F., et al. (2017) · Neural Plasticity · doi:10.1155/2017/3270725 · Cited by 33
Review: PrP 106‐126 – 25 years after
Forloni, G., Chiesa, R., Bugiani, O., Salmona, M., & Tagliavini, F. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12538 · Cited by 34
Lane, R. F., Shineman, D. W., Steele, J., Lee, L. H., & Fillit, H. M. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00007-6 · Cited by 35
Palesi, F., Vitali, P., Chiarati, P., Castellazzi, G., Caverzasi, E., Pichiecchio, A., Tibaldi, E. C., D’Amore, F., D'Errico, I., Sinforiani, E., et al. (2011) · Neurology Research International · doi:10.1155/2012/517876 · Cited by 34
Hanna, A., Iremonger, K., Das, P., Dickson, D., Golde, T., & Janus, C. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt124 · Cited by 38
Slachevsky, A., Forno, G., Barraza, P., Mioshi, E., Delgado, C., Lillo, P., Henríquez, F., Bravo, E., Farias, M., Muñoz‐Neira, C., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09260-w · Cited by 33
Odor identification and cognitive function in the Beaver Dam Offspring Study
Schubert, C. R., Cruickshanks, K. J., Fischer, M., Huang, G.-H., Klein, R., Pankratz, N., Zhong, W., & Nondahl, D. M. (2013) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2013.809701 · Cited by 33
Adamson, M. M., Hutchinson, J. B., Shelton, A. L., Wagner, A. D., & Taylor, J. L. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2011.04.022 · Cited by 34
Fan, S., Ponisio, M. R., Xiao, P., Ha, S. M., Chakrabarty, S., Lee, J. J., Flores, S. E., LaMontagne, P., Gordon, B. A., Raji, C. A., et al. (2024) · Radiology · doi:10.1148/radiol.231442 · Cited by 33
Hunter, S., & Brayne, C. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt108 · Cited by 31
Reith, F. H., Koran, M. E. I., Davidzon, G., & Zaharchuk, G. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6573 · Cited by 31
Amyloid-β and Glucose Metabolism in Alzheimer's Disease
Furst, A. J., & Lal, R. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0066 · Cited by 33
Alpha- and beta-synuclein expression in Parkinson disease with and without dementia
Beyer, K., Ispierto, L., Latorre, P., TOLOSA, E. S., & Ariza, A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.05.049 · Cited by 33
Metadata
- Authors
- Braak, H., & Braak, E.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Braak, H
- ORCID
- Braak, H
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 1997-07
- Volume
- 18
- Issue
- 4
- Pages
- S85-S88
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2015001118
- Cited by
- 410
- References
- 39
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 21 · 2022: 7 · 2021: 16 · 2020: 20 · 2019: 13 · 2018: 20 · 2017: 12 · 2016: 16 · 2015: 21 · 2014: 16 · 2013: 22 · 2012: 25
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neuropathologic diagnosis, neurofibrillary tangles, neuropil threads, amyloid plaques, silver staining, Lewy body disease, brain aging
- MeSH terms
- Aged, Aging, Alzheimer Disease, Brain, Humans, Severity of Illness Index, Neurofibrillary Tangles, Disease Progression, Neuropil Threads, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review